Inovio Pharmaceuticals Stock Market Value
| INO Stock | USD 1.61 0.08 5.23% |
| Symbol | Inovio |
Will Stock sector continue expanding? Could Inovio diversify its offerings? Factors like these will boost the valuation of Inovio Pharmaceuticals. Market participants price Inovio higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Inovio Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Inovio Pharmaceuticals requires distinguishing between market price and book value, where the latter reflects Inovio's accounting equity. The concept of intrinsic value—what Inovio Pharmaceuticals' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Inovio Pharmaceuticals' price substantially above or below its fundamental value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Inovio Pharmaceuticals' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Inovio Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Inovio Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Inovio Pharmaceuticals.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Inovio Pharmaceuticals on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Inovio Pharmaceuticals or generate 0.0% return on investment in Inovio Pharmaceuticals over 90 days. Inovio Pharmaceuticals is related to or competes with Acumen Pharmaceuticals, Opus Genetics, Agenus, Seer, Spero Therapeutics, Fate Therapeutics, and Seres Therapeutics. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of D... More
Inovio Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Inovio Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Inovio Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 36.52 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 6.38 |
Inovio Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inovio Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Inovio Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Inovio Pharmaceuticals historical prices to predict the future Inovio Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (2.87) |
Inovio Pharmaceuticals January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (2.86) | |||
| Mean Deviation | 3.69 | |||
| Coefficient Of Variation | (1,107) | |||
| Standard Deviation | 5.25 | |||
| Variance | 27.57 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (2.87) | |||
| Maximum Drawdown | 36.52 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 6.38 | |||
| Skewness | (1.25) | |||
| Kurtosis | 6.39 |
Inovio Pharmaceuticals Backtested Returns
Inovio Pharmaceuticals holds Efficiency (Sharpe) Ratio of -0.0903, which attests that the entity had a -0.0903 % return per unit of risk over the last 3 months. Inovio Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Inovio Pharmaceuticals' Market Risk Adjusted Performance of (2.86), risk adjusted performance of (0.06), and Standard Deviation of 5.25 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.17, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Inovio Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Inovio Pharmaceuticals is expected to be smaller as well. At this point, Inovio Pharmaceuticals has a negative expected return of -0.47%. Please make sure to check out Inovio Pharmaceuticals' total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Inovio Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.58 |
Modest predictability
Inovio Pharmaceuticals has modest predictability. Overlapping area represents the amount of predictability between Inovio Pharmaceuticals time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Inovio Pharmaceuticals price movement. The serial correlation of 0.58 indicates that roughly 58.0% of current Inovio Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.58 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.11 |
Pair Trading with Inovio Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inovio Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inovio Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Inovio Stock
| 0.7 | CVX | Chevron Corp Earnings Call Tomorrow | PairCorr |
| 0.64 | XOM | Exxon Mobil Corp Earnings Call Tomorrow | PairCorr |
| 0.6 | BA | Boeing | PairCorr |
| 0.56 | INTC | Intel | PairCorr |
| 0.52 | AA | Alcoa Corp | PairCorr |
The ability to find closely correlated positions to Inovio Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inovio Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inovio Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inovio Pharmaceuticals to buy it.
The correlation of Inovio Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inovio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inovio Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inovio Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Inovio Pharmaceuticals Correlation, Inovio Pharmaceuticals Volatility and Inovio Pharmaceuticals Performance module to complement your research on Inovio Pharmaceuticals. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Inovio Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.